Header Logo

Connection

Rami Doukky to Female

Back to Details
This is a "connection" page, showing publications Rami Doukky has written about Female.
Rami Doukky
Connection Strength
2.482
Female
  1. Invasive therapy versus conservative therapy for patients with stable coronary artery disease: An updated meta-analysis. Clin Cardiol. 2021 May; 44(5):675-682.
    View in: PubMed
    Score: 0.056
  2. The Prognostic Value of MPI in CKD: Can we do better? J Nucl Cardiol. 2022 Feb; 29(1):155-157.
    View in: PubMed
    Score: 0.056
  3. The diagnostic and prognostic value of near-normal perfusion or borderline ischemia on stress myocardial perfusion imaging. J Nucl Cardiol. 2022 04; 29(2):826-835.
    View in: PubMed
    Score: 0.054
  4. The prognostic utility of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease: The largest cohort to date. J Nucl Cardiol. 2022 Feb; 29(1):101-110.
    View in: PubMed
    Score: 0.053
  5. BRASH Syndrome with Hyperkalemia: An Under-Recognized Clinical Condition. Methodist Debakey Cardiovasc J. 2020 Jul-Sep; 16(3):241-244.
    View in: PubMed
    Score: 0.053
  6. The prognostic value of regadenoson SPECT myocardial perfusion imaging: The largest cohort to date. J Nucl Cardiol. 2021 12; 28(6):2799-2807.
    View in: PubMed
    Score: 0.053
  7. Utilization Effects of the Affordable Care Act on Implantable Cardioverter-Defibrillator Therapy. J Am Coll Cardiol. 2020 04 14; 75(14):1714-1717.
    View in: PubMed
    Score: 0.052
  8. Impact of pretransplant mitral annular calcification on the incidence of cardiac events after renal transplantation. Nephrol Dial Transplant. 2020 03 01; 35(3):526-533.
    View in: PubMed
    Score: 0.052
  9. Myocardial perfusion imaging and coronary calcium score: A marriage made in heaven. J Nucl Cardiol. 2021 10; 28(5):2097-2099.
    View in: PubMed
    Score: 0.051
  10. Prognostic value of regadenoson stress myocardial perfusion imaging in patients with left bundle branch block or ventricular paced rhythm. J Nucl Cardiol. 2021 06; 28(3):967-977.
    View in: PubMed
    Score: 0.049
  11. The diagnostic and prognostic utility of risk factors defined by the AHA/ACCF on the evaluation of cardiac disease in liver transplantation candidates. BMC Cardiovasc Disord. 2019 05 02; 19(1):102.
    View in: PubMed
    Score: 0.049
  12. Bleeding Risk of Transesophageal Echocardiography in Patients With Esophageal Varices. J Am Soc Echocardiogr. 2019 05; 32(5):674-676.e2.
    View in: PubMed
    Score: 0.048
  13. Use of ultrasound enhancing agents in transesophageal echocardiography to improve interpretive confidence of left atrial appendage thrombus. Echocardiography. 2019 02; 36(2):362-369.
    View in: PubMed
    Score: 0.048
  14. Usefulness of Oximetry Paradoxus to Diagnose Cardiac Tamponade. Am J Cardiol. 2019 02 01; 123(3):498-506.
    View in: PubMed
    Score: 0.047
  15. Prognostic significance of ischemic electrocardiographic changes with regadenoson stress myocardial perfusion imaging. J Nucl Cardiol. 2020 10; 27(5):1521-1532.
    View in: PubMed
    Score: 0.047
  16. Clinical predictors and outcomes of patients with pericardial effusion in chronic kidney disease. Clin Cardiol. 2018 May; 41(5):660-665.
    View in: PubMed
    Score: 0.046
  17. The long-term prognostic value of highly sensitive cardiac troponin I in patients with acute pulmonary embolism. Clin Cardiol. 2017 Dec; 40(12):1271-1278.
    View in: PubMed
    Score: 0.045
  18. The prognostic value of heart rate response during vasodilator stress myocardial perfusion imaging in patients with end-stage renal disease undergoing renal transplantation. J Nucl Cardiol. 2019 06; 26(3):814-822.
    View in: PubMed
    Score: 0.044
  19. The significance of post-stress decrease in left ventricular ejection fraction in patients undergoing regadenoson stress gated SPECT myocardial perfusion imaging. J Nucl Cardiol. 2018 08; 25(4):1313-1323.
    View in: PubMed
    Score: 0.042
  20. Impact of integrating heart rate response with perfusion imaging on the prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol. 2017 10; 24(5):1666-1671.
    View in: PubMed
    Score: 0.040
  21. Derivation and validation of E/e' ratio as a parameter in the evaluation of left atrial appendage thrombus formation in patients with nonvalvular atrial fibrillation. Int J Cardiovasc Imaging. 2016 Sep; 32(9):1349-1356.
    View in: PubMed
    Score: 0.040
  22. Impact of a regimented aminophylline administration protocol on the burden of regadenoson-induced ischemia detected by SPECT myocardial perfusion imaging. J Nucl Cardiol. 2017 10; 24(5):1571-1578.
    View in: PubMed
    Score: 0.040
  23. Impact of Appropriate Use on the Estimated Radiation Risk to Men and Women Undergoing Radionuclide Myocardial Perfusion Imaging. J Nucl Med. 2016 Aug; 57(8):1251-7.
    View in: PubMed
    Score: 0.040
  24. Impact of Diastolic Function Parameters on the Risk for Left Atrial Appendage Thrombus in Patients with Nonvalvular Atrial Fibrillation: A Prospective Study. J Am Soc Echocardiogr. 2016 06; 29(6):545-53.
    View in: PubMed
    Score: 0.040
  25. Impact of Physical Inactivity on Mortality in Patients With Heart Failure. Am J Cardiol. 2016 Apr 01; 117(7):1135-43.
    View in: PubMed
    Score: 0.039
  26. Impact of B-type natriuretic peptide level on the risk of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation: a prospective study. Cardiovasc Ultrasound. 2016 Jan 16; 14:4.
    View in: PubMed
    Score: 0.039
  27. Impact of Dietary Sodium Restriction on Heart Failure Outcomes. JACC Heart Fail. 2016 Jan; 4(1):24-35.
    View in: PubMed
    Score: 0.039
  28. The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol. 2017 02; 24(1):112-118.
    View in: PubMed
    Score: 0.039
  29. Appropriate use criteria for SPECT myocardial perfusion imaging: Are they appropriate for women? J Nucl Cardiol. 2016 08; 23(4):695-705.
    View in: PubMed
    Score: 0.038
  30. Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease. J Nucl Cardiol. 2016 06; 23(3):560-9.
    View in: PubMed
    Score: 0.038
  31. The prognostic value of regadenoson stress: Has the case been made? J Nucl Cardiol. 2015 Aug; 22(4):608-10.
    View in: PubMed
    Score: 0.037
  32. Impact of insurance carrier, prior authorization, and socioeconomic status on appropriate use of SPECT myocardial perfusion imaging in private community-based office practice. Clin Cardiol. 2015 May; 38(5):267-73.
    View in: PubMed
    Score: 0.037
  33. Diagnostic and prognostic significance of ischemic electrocardiographic changes with regadenoson-stress myocardial perfusion imaging. J Nucl Cardiol. 2015 Aug; 22(4):700-13.
    View in: PubMed
    Score: 0.037
  34. The significance of automatically measured transient ischemic dilation in identifying severe and extensive coronary artery disease in regadenoson, single-isotope technetium-99m myocardial perfusion SPECT. J Nucl Cardiol. 2015 Jun; 22(3):526-34.
    View in: PubMed
    Score: 0.037
  35. Prognostic implications of stress modality on mortality risk and cause of death in patients undergoing office-based SPECT myocardial perfusion imaging. J Nucl Cardiol. 2016 Apr; 23(2):202-11.
    View in: PubMed
    Score: 0.037
  36. The prognostic value of undetectable highly sensitive cardiac troponin I in patients with acute pulmonary embolism. Chest. 2015 Mar; 147(3):685-694.
    View in: PubMed
    Score: 0.037
  37. Coronary Computed Tomographic Angiography in the Evaluation of Liver Transplant Candidates. Angiology. 2015 Oct; 66(9):803-10.
    View in: PubMed
    Score: 0.036
  38. Severe chronic kidney disease as a predictor of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: A substudy of the ASSUAGE and ASSUAGE-CKD trials. J Nucl Cardiol. 2015 Oct; 22(5):1008-18.
    View in: PubMed
    Score: 0.036
  39. Cardiac imaging for the assessment of patients being evaluated for kidney or liver transplantation. J Nucl Cardiol. 2015 Apr; 22(2):282-96.
    View in: PubMed
    Score: 0.036
  40. Are cardiologists truly better at appropriately selecting patients for stress myocardial perfusion imaging? Int J Cardiol. 2014 Sep; 176(1):285-6.
    View in: PubMed
    Score: 0.035
  41. Rheumatic heart disease in modern urban America: a cohort study of immigrant and indigenous patients in Chicago. Int J Cardiol. 2014 Jul 15; 175(1):178-80.
    View in: PubMed
    Score: 0.035
  42. The value of diastolic function parameters in the prediction of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Cardiovasc Ultrasound. 2014 Feb 25; 12:10.
    View in: PubMed
    Score: 0.034
  43. The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: a substudy of the ASSUAGE trial. J Nucl Cardiol. 2014 Jun; 21(3):496-502.
    View in: PubMed
    Score: 0.034
  44. Hyperthyroid atrial fibrillation: does it matter for stroke risk? Cardiology. 2014; 128(1):51-3.
    View in: PubMed
    Score: 0.034
  45. Age and gender as predictors of benefit from aminophylline administration in patients undergoing regadenoson stress myocardial perfusion imaging: a substudy of the ASSUAGE trial. Am J Ther. 2013 Nov-Dec; 20(6):622-9.
    View in: PubMed
    Score: 0.034
  46. Reply: To PMID 23496263. Echocardiography. 2013 Oct; 30(9):1122.
    View in: PubMed
    Score: 0.033
  47. Impact of appropriate use on the prognostic value of single-photon emission computed tomography myocardial perfusion imaging. Circulation. 2013 Oct 08; 128(15):1634-43.
    View in: PubMed
    Score: 0.033
  48. A simple validated clinical tool to predict the absence of coronary artery disease in patients with systolic heart failure of unclear etiology. Am J Cardiol. 2013 Oct 15; 112(8):1165-70.
    View in: PubMed
    Score: 0.033
  49. B-type natriuretic peptide predicts left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Echocardiography. 2013 Sep; 30(8):889-95.
    View in: PubMed
    Score: 0.032
  50. The prognostic value of cardiac SPECT performed at the primary care physician's office. J Nucl Cardiol. 2013 Aug; 20(4):519-28.
    View in: PubMed
    Score: 0.032
  51. External validation of a novel transthoracic echocardiographic tool in predicting left atrial appendage thrombus formation in patients with nonvalvular atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2013 Sep; 14(9):876-81.
    View in: PubMed
    Score: 0.032
  52. The safety and tolerability of regadenoson in patients with end-stage renal disease: the first prospective evaluation. J Nucl Cardiol. 2013 Apr; 20(2):205-13.
    View in: PubMed
    Score: 0.032
  53. Attenuation of the side effect profile of regadenoson: a randomized double-blind placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging and have severe chronic kidney disease--the ASSUAGE-CKD trial. Int J Cardiovasc Imaging. 2013 Jun; 29(5):1029-37.
    View in: PubMed
    Score: 0.032
  54. Attenuation of the side effect profile of regadenoson: a randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging. "The ASSUAGE trial". J Nucl Cardiol. 2012 Jun; 19(3):448-57.
    View in: PubMed
    Score: 0.030
  55. Soft tissue attenuation patterns in stress myocardial perfusion SPECT images: a comparison between supine and upright acquisition systems. J Nucl Cardiol. 2011 Apr; 18(2):281-90.
    View in: PubMed
    Score: 0.028
  56. Ambulatory cardiac single-photon emission computed tomography at the primary care physician's office: a descriptive study. J Ambul Care Manage. 2010 Oct-Dec; 33(4):328-35.
    View in: PubMed
    Score: 0.027
  57. Prevalence and predictors of Twiddler's syndrome. Pacing Clin Electrophysiol. 2023 Jun; 46(6):454-458.
    View in: PubMed
    Score: 0.016
  58. Feasibility and safety of laser balloon pulmonary vein isolation in patients with prior left atrial appendage occlusion device implantation. J Cardiovasc Electrophysiol. 2022 11; 33(11):2389-2393.
    View in: PubMed
    Score: 0.015
  59. Novel oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2022 06; 99(7):2101-2110.
    View in: PubMed
    Score: 0.015
  60. Sex Differences in COVID-19 Hospitalization and Mortality. J Womens Health (Larchmt). 2021 05; 30(5):646-653.
    View in: PubMed
    Score: 0.014
  61. Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls. J Nucl Cardiol. 2021 02; 28(1):104-111.
    View in: PubMed
    Score: 0.013
  62. Cochrane corner: transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk. Heart. 2020 07; 106(14):1043-1045.
    View in: PubMed
    Score: 0.013
  63. Impact of chronic thrombocytopenia on in-hospital outcomes and healthcare resource utilization after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2020 08; 96(2):413-421.
    View in: PubMed
    Score: 0.013
  64. Quadripolar versus bipolar leads in cardiac resynchronization therapy: An analysis of the National Cardiovascular Data Registry. Heart Rhythm. 2020 01; 17(1):81-89.
    View in: PubMed
    Score: 0.012
  65. Intermittent pneumatic compression in patients with ESRD. A systematic review. Hemodial Int. 2019 10; 23(4):433-444.
    View in: PubMed
    Score: 0.012
  66. Impact of Hospice and Palliative Care Service Utilization on All-Cause 30-Day Readmission Rate for Older Adults Hospitalized with Heart Failure. Am J Hosp Palliat Care. 2019 Jul; 36(7):623-629.
    View in: PubMed
    Score: 0.012
  67. Association between lifetime risk of atrial fibrillation and mortality in the oldest old. Clin Cardiol. 2018 May; 41(5):634-639.
    View in: PubMed
    Score: 0.011
  68. Design of a bilevel clinical trial targeting adherence in heart failure patients and their providers: The Congestive Heart Failure Adherence Redesign Trial (CHART). Am Heart J. 2018 Jan; 195:139-150.
    View in: PubMed
    Score: 0.011
  69. Mean Arterial Pressure to Central Venous Pressure Ratio: A Novel Marker for Right Ventricular Failure After Left Ventricular Assist Device Placement. J Card Fail. 2017 Jun; 23(6):446-452.
    View in: PubMed
    Score: 0.011
  70. Indirect Comparison of Novel Oral Anticoagulants in Women with Nonvalvular Atrial Fibrillation. J Womens Health (Larchmt). 2017 03; 26(3):214-221.
    View in: PubMed
    Score: 0.010
  71. Lipoprotein(a) and Increased Cardiovascular Risk in Women. Clin Cardiol. 2016 Feb; 39(2):96-102.
    View in: PubMed
    Score: 0.010
  72. The Impact of Hospital and Surgeon Volume on In-Hospital Mortality of Ventricular Assist Device Recipients. J Card Fail. 2016 Mar; 22(3):226-31.
    View in: PubMed
    Score: 0.010
  73. Outcomes after inappropriate nuclear myocardial perfusion imaging: A meta-analysis. J Nucl Cardiol. 2016 08; 23(4):680-9.
    View in: PubMed
    Score: 0.009
  74. Congestive heart failure adherence redesign trial: a pilot study. BMJ Open. 2014 Dec 04; 4(12):e006542.
    View in: PubMed
    Score: 0.009
  75. Predictors of diastolic dysfunction among minority patients with newly diagnosed type 2 diabetes. Diabetes Res Clin Pract. 2010 May; 88(2):189-95.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.